From: Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)
Upregulated miRNAs | Downregulated miRNAs | ||||
---|---|---|---|---|---|
miRNAs NMO vs HCs | Fold change | p value | miRNAs NMO vs HCs | Fold change | p value |
hsa-miR-760 (#^) | 10.6 | 0.00021 | hsa-miR-7 | 0.19 | 0.00034 |
hsa-miR-423-3p (#) | 1.6 | 0.0008 | hsa-miR-140 | 0.4 | 0.00042 |
hsa-miR-660 (#) | 6.1 | 0.00118 | hsa-miR-22 | 0.57 | 0.00108 |
hsa-miR-135a (#^) | 5.3 | 0.00202 | hsa-miR-143 | 0.11 | 0.00109 |
hsa-miR-135b (#^) | 8 | 0.00329 | hsa-miR-150 | 0.35 | 0.00126 |
hsa-miR-1180 | 2.8 | 0.00562 | hsa-let-7b | 0.51 | 0.00221 |
hsa-miR-203 (#) | 6.5 | 0.00862 | hsa-miR-2110 | 0.14 | 0.00541 |
hsa-miR-18a | 1.7 | 0.01101 | hsa-miR-29a | 0.28 | 0.00612 |
hsa-miR-20b | 1.9 | 0.01591 | hsa-miR-342 | 0.24 | 0.0103 |
hsa-miR-100 (#) | 2.8 | 0.02 | hsa-miR-10b | 0.21 | 0.01041 |
hsa-miR-205 | 6.5 | 0.0228 | hsa-miR-1227 | 0.12 | 0.01501 |
hsa-miR-134 (#^) | 4.6 | 0.02493 | hsa-miR-21 | 0.54 | 0.01947 |
hsa-miR-542 | 6.5 | 0.03172 | hsa-miR-133b | 0.16 | 0.01964 |
hsa-miR-125b (#^) | 1.7 | 0.0413 | hsa-miR-532-5p | 0.33 | 0.02214 |
hsa-miR-551b | 5.7 | 0.04761 | hsa-miR-30e | 0.47 | 0.03266 |
hsa-miR-454 | 2.1 | 0.04839 | hsa-miR-133a | 0.24 | 0.03284 |
hsa-miR-138 (#^) | 3.5 | 0.04892 | hsa-miR-139 | 0.23 | 0.04032 |
hsa-miR-124 | 0.33 | 0.0424 | |||
hsa-miR-130b | 0.44 | 0.04353 | |||
hsa-miR-378 | 0.48 | 0.0439 | |||
hsa-miR-215 | 0.28 | 0.04642 | |||
hsa-miR-411 | 0.19 | 0.04853 | |||
hsa-miR-30a | 0.32 | 0.04876 | |||
hsa-miR-27a | 0.46 | 0.04906 | |||
hsa-miR-107 | 0.7 | 0.05042 |